Styczyński T. Regionalne zespoły bólowe. In: Zimmermann-Gorska I, ed. Postępy reumatologii klinicznej. Warszawa: Wydawnictwo Lekarskie PZWL ; 2014: 397–411.
Hoy D, Brooks P, Blyth F, et al. The epidemiology of low back pain. Best Pract Res Clin Rheumatol 2010; 24(6): 769–781.
Majid K, Truumees E. Epidemiology and natural history of low back pain. Semin Spine Surg 2008; 20: 87–92.
Branco JC, Rodrigues AM, Gouveia N, et al. Prevalence of rheumatic and musculoskeletal diseases and their i quality of life, physical function and mental health in Portugal: results from EpiRheumaPt – a national health sui RMD Open 2016; 2: e000166.impact on healthrelated
S hmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US adults: National Health and NutritSurvey 2009–2010. Arthritis Care Res 2016; Mar 18, doi: 10.1002/acr.22890 [in press]on Examination
L ukas C, Dougados M, Combe B. Factors associated with a bad functional prognosis in early inflammatory back pain: results from the DESIR cohort. RMD Open 2015; 2: e000204.
A mirdelfan K, McRoberts P, Deer TR . The differential diagnosis of low back pain: a primer on the evolving paradigm. Neuromodulation 2014; 17(Suppl. 2): 11–17.
D ePalma MJ, Ketchum JM, Saullo T. What is the cause of chronic low back pain and does age play a role? Pain Med 2011;12(2): 224–233.
H u R, Mustard CA , Burns C. Epidemiology of incident spinal fracture in a general population. Spine 1996; 21(4): 492–499.
Neva MH, Häkkinen A, Isomäki P, et al. Chronic back pain in patients with rheumatoid arthritis and in a control population:prevalence and disability – a 5-year follow-up. Rheumatology 2011; 50(9): 1635–1639, doi: 10.1093/rheumatology/ker173.
Melloh M, Elfering A, Egli Presland C, et al. Identification of prognostic factors for chronicity in patients with low back pain:a review of screening instruments. Int Orthop 2009; 33(2): 301–313.
Dagenais S, Tricco AC , Haldeman S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine 2010; 10(6): 514-529.
Webster BS, Bauer AZ , Choi Y, et al. Iatrogenic consequences of early magnetic resonance imaging in acute, work-related,disabling low back pain. Spine 2013; 38(22): 1939–1946.
Webster BS, Choi Y, Bauer AZ , et al. The cascade of medical services and associated longitudinal costs due to nonadherent magnetic resonance imaging for low back pain. Spine 2014; 39(17): 1433–1440.
Monnin D, Courvoisier DS , Genevay S. Modifying beliefs about back pain: a pilot study among healthcare professionals.Patient Educ Couns 2016; 99(4): 665–670.
Salzberg LD , Manusov EG. Management options for patients with chronic back pain without an etiology. Health Serv Insights 2013; 28: 33–38.
Weisman MH, Witter JP, Reveille JD. The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009–2010. Ann Rheum Dis 2013; 72(3): 369–373.
Heuft-Dorenbosch L, Landewé R, Weijers R, et al. Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic. Ann Rheum Dis 2007; 66(1): 92–98.
Kramza J, Kucharz E.J. Mechaniczny ból krzyża – rozpoznanie i leczenie. Świat Med Farm 2013; 8(147): 24–31.
Reveille JD, Weisman MH. The epidemiology of back pain, axial spondyloarthritis and HLA -B27 in the United States. Am J Med Sci 2013; 345(6): 431–436.
Kucharz EJ. Reumatologia i angiologia. In: Duława J, ed. Vademecum medycyny wewnętrznej. Warszawa: Wydawnictwo Lekarskie PZWL ; 2015: 396–433.
Kucharz EJ. Spondyloartropatie seronegatywne. In: Steciwko A, ed. Medycyna rodzinna – co nowego?. Wrocław: Cornetis;2010; 1: 224–228.
Poddubnyy D, Rudwaleit M, Haibel H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patientswith axial spondyloarthritis. Ann Rheum Dis 2011; 70(8): 1369–1374
van Tubergen A. The changing clinical picture and epidemiology of spondyloarthritis. Nature Reviews Rheumatology 2015;11: 110–118.
Akkoc N. Are spondyloarthropathies as common as rheumatoid arthritis worldwide? Curr Rheumatol Rep 2008; 10(5): 371––378.
Stolwijk C, Boonen A, van Tubergen A, et al. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am 2012; 38(3):441–476.
Taurog JD, Chhabra A, Colbert RA . Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 2016; 374(26): 2563–2574.
Kroon FP, van der Burg LR , Ramiro S, et al. Nonsteroidal antiinflammatory drugs for axial spondyloarthritis: a C ochrane review.J Rheumatol 2016; 43(3): 607–617.
an den Berg R, van der Heijde DM. How should we diagnose spondyloarthritis according to the ASAS classification criteria:a guide for practicing physicians. Pol Arch Med Wew 2010; 120(11): 452–457.